Arcus Biosciences RCUS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 13.60 | 107.58 | -1.30 | -142,000 | -135 | |
| 2025Q2 | 8.14 | -400.00 | 0.05 | -8,000 | ||
| 2025Q1 | 7.85 | 109.91 | -1.14 | -122,000 | -112 | |
| 2024Q4 | 14.89 | 113.19 | -1.03 | -103,000 | -94 | |
| 2024Q3 | 15.29 | 116.67 | -1.02 | -105,000 | -92 | |
| 2024Q2 | 15.23 | 112.77 | -1.04 | -106,000 | -93 | |
| 2024Q1 | 18.88 | 400.00 | -0.05 | -16,000 | -4 | |
| 2023Q4 | 19.10 | 110.98 | -1.08 | -91,000 | -81 | |
| 2023Q3 | 17.95 | 115.94 | -0.94 | -80,000 | -71 | |
| 2023Q2 | 20.31 | 112.16 | -1.04 | -83,000 | -75 | |
| 2023Q1 | 18.24 | 110.26 | -1.09 | -86,000 | -80 | |
| 2022Q4 | 20.68 | 110.45 | 18.76 | -0.93 | -74,000 | -67 |
| 2022Q3 | 26.16 | 107.78 | 28.27 | -0.90 | -69,559 | -65 |
| 2022Q2 | 25.34 | 103.81 | 31.64 | -0.92 | -69,162 | -67 |
| 2022Q1 | 31.56 | 100.29 | 42.45 | -0.96 | -67,180 | -68 |
| 2021Q4 | 40.47 | 100.03 | 3.99 | 281,267 | 279 | |
| 2021Q3 | 34.87 | 100.21 | -1.11 | -78,136 | -78 | |
| 2021Q2 | 27.46 | 100.22 | -1.09 | -76,136 | -76 | |
| 2021Q1 | 28.08 | 100.21 | -1.08 | -72,747 | -73 | |
| 2020Q4 | 25.96 | 100.31 | -0.87 | -52,012 | -52 |